Shares of Nuburu (BURU) slid 9.9% to $0.13 after the defense-laser company filed a new S-1 registration statement with the SEC on July 13, 2026 — its latest move to sell more stock to investors. The fresh filing lands just five months after a $12 million public offering and a reverse stock split designed to keep the company on the NYSE American exchange, raising urgent questions about how much shareholder value is left to dilute.
• Another Round of Share Sales, Same Survival Playbook. The new S-1, filed today with the SEC, sets up yet another shelf of securities Nuburu can sell "from time to time." This follows a February offering that issued roughly 58.4 million shares and 50.7 million pre-funded warrants at just $0.11 per share , plus common warrants representing 150% coverage on top of that . Shareholders also approved up to $50 million in discounted securities through non-public offerings in March. For a company with a market cap of just ~$25 million, the cumulative overhang — meaning shares that could flood the market — is enormous.
• Almost No Revenue to Justify the Cash Burn. Nuburu generated just $407,644 in revenue in Q1 2026, split between two small Italian subsidiaries.
Base 2026 revenue visibility is only about $1.02 million , while operating income was -$18.4 million and net loss reached -$79.1 million on a trailing basis, with diluted losses of -$2.25 per share. The company itself warns it "anticipates that it will incur net losses for the foreseeable future."
• Delisting Risk Hasn't Gone Away. Trading was halted in February when the stock fell below $0.10, forcing a 1-for-4.99 reverse split.
NYSE American rules restrict another reverse split in the near term , meaning if shares drift below $0.10 again, the stock faces another halt and potential delisting. At $0.13, the cushion is razor-thin.
• Big Ambitions, Little Proof. Nuburu is pitching a sweeping defense-tech transformation, including a binding agreement to acquire 70% of Italian firm Tekne at a €52 million pre-money valuation and projected 2026–2029 gross revenue of roughly $336 million. But with operating cash flow at -$16.1 million and a current ratio of just 0.75, every ambitious deal requires selling more stock — the very cycle that is crushing existing shareholders today.